Prognostic Significance of Monocytic-like Phenotype in AML patients treated with Venetoclax and Azacytidine
Key Points
treatment
The impact of ABO compatibility on allogeneic hematopoietic cell transplantation outcomes: a contemporary and comprehensive study from the transplant complications working party of the EBMT
Abstract
Ross L. Levine, MD
Levine, Ross
Physician-Scientist
Memorial Sloan-Kettering Cancer Center
Online Profile:
John Letterio, MD
Letterio, John
Professor
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
Online Profile:
Michael Joyce, MD, PhD
Joyce, Michael
Pediatric Hematologist Oncologist
Wolfson Children's Hospital
Daniel Landau, MD
Landau, Daniel
Hematologist/Oncologist
MUSC Health University Medical Center Extension
Hawk Kim, MD, PhD
Kim, Hawk
Professor
Gachon University Gil Medical Center
Mohamed A. Kharfan Dabaja, MD, MBA
Kharfan-Dabaja, Mohamed
Hematologist Oncologist
Mayo Clinic - Jacksonville
Rick J Jones, MD
Jones, Rick
Professor of Oncology
Johns Hopkins University
Support is Growing to Restore Funding to CDMRP and BMFRP Research Programs
Thanks to the efforts of our AAMDSIF bone marrow failure community and coalition partners, a bipartisan group of 105 U.S.